Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a
Authors:
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 58 (1) , 15-19
Abstract
In an open prospective pilot trial, we tested the effect of recombinant interferon alpha-2a (rIFN alpha-2a) on thrombocytosis in myeloproliferative disorders (MPD). Since October 1986, 13 patients with MPD (4 with chronic granulocytic leukemia, 4 with polycythemia vera, 3 with essential thrombocythemia and 2 with myeloid metaplasia) were treated with rIFN alpha-2a. Platelet counts decreased in all treated patients within 2 to 10 weeks from a median value of 1,050×109/l (range 610−1,940×109/l) to 340×109/l (range 230−495×109/l). The response was dose-dependent. In 11 patients we observed a simultaneous reduction of the white blood cell count. Six patients still continue the IFN alpha-2a therapy. In 7 treatment was discontinued, because of chronic side effects in 3, and because of noncompliance in one. In these patients, thrombocytosis recurred after discontinuation of the therapy. These results show that rIFN alpha-2a is effective in controlling thrombocytosis in MPD. However, the long-term benefit of interferon in these disorders remains to be established.Keywords
This publication has 22 references indexed in Scilit:
- Interferon alfa-2b in the treatment of chronic granulocytic leukemia.1986
- Chronic myeloid leukemiaThe American Journal of Medicine, 1986
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- α2-Interferon: erste Behandlungsergebnisse bei der chronischen myeloischen LeukämieDMW - Deutsche Medizinische Wochenschrift, 1986
- Evening Administration of Alpha InterferonNew England Journal of Medicine, 1985
- Human Leukocyte Interferon to Control Thrombocytosis in Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1983
- Neurologic Manifestations of Essential ThrombocythemiaAnnals of Internal Medicine, 1983
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Arterial thrombosis in essential thrombocythemiaAmerican Heart Journal, 1978
- Polycythæmia Vera. Course and Prognosis1Acta Medica Scandinavica, 1950